Early research (Phase 1)Ended earlyNCT01374503What this trial is testingFirst in Man Study of ALX-0651, a Nanobody Inhibiting CXCR4Who this might be right forHealthy Volunteers Ablynx, a Sanofi company 52
Early research (Phase 1)Study completedNCT01359657What this trial is testingAnti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Bristol-Myers Squibb 46
Testing effectiveness (Phase 2)Study completedNCT01072734What this trial is testingAuto-immunity in Lupus Patients After Influenza VaccineWho this might be right forSystemic Lupus Erythematosus (SLE) Assistance Publique - Hôpitaux de Paris 28
Not applicableStudy completedNCT01295242What this trial is testingNatural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)Who this might be right forPapillomavirus Infections University of Washington 409
Testing effectiveness (Phase 2)Study completedNCT01905475What this trial is testingCXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)Who this might be right forLarge Reperfused ST-Elevation Myocardial Infarction Polyphor Ltd. 120
Not applicableUnknownNCT04799730What this trial is testingExpression of CXCR4 in Patients With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Sohag University 100
Early research (Phase 1)Study completedNCT00063804What this trial is testingSafety of AMD070 When Administered Alone or Boosted With Low-Dose Ritonavir in HIV Uninfected MenWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)UnknownNCT04684472What this trial is testingModified CD19 CAR-T in Patients With Relapsed or Refractory CD19+ B-cell MalignanciesWho this might be right forRefractory B-Cell Non-Hodgkin LymphomaRefractory Leukemia Liqun Zou 18
Not applicableUnknownNCT06234319What this trial is testingCXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain GliomaWho this might be right forGlioma Xiao Chen 60
Large-scale testing (Phase 3)Ended earlyNCT06125028What this trial is testing[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone LymphomaWho this might be right forMarginal Zone Lymphoma Pentixapharm AG 8
Not applicableLooking for participantsNCT06690736What this trial is testingChemokine Receptor 4 PET/CT Imaging of CXCR4-Related DiseasesWho this might be right forCXCR4-related DiseaseTumorPositron Emission Tomography+1 more Tianjin Medical University 200
Very early researchUnknownNCT04504526What this trial is testingValue of Chemokine Receptor CXCR4 Imaging for Diagnosis and Prognostic Evaluation in Lymphoproliferative DiseasesWho this might be right forLymphomaMultiple MyelomaLeukemia First Affiliated Hospital of Fujian Medical University 50
Not applicableStudy completedNCT01686685What this trial is testingCorrelation of CXCR4 Expression in Premature Infants With a Diagnosis of Autism at 24 MonthsWho this might be right forAutism Spectrum DisorderComplication of Prematurity Hadassah Medical Organization 400
Not applicableWithdrawnNCT03087370What this trial is testingA Retrospective and Prospective Natural History Study of Patients With WHIM SyndromeWho this might be right forWHIM Syndrome X4 Pharmaceuticals
Very early researchUnknownNCT06086327What this trial is testingApplication of 68Ga-Pentixafor PET/CT for ThymomaWho this might be right forThymoma Peking Union Medical College Hospital 100
Early research (Phase 1)Ended earlyNCT02737072What this trial is testingLY2510924 and Durvalumab in Participants With Solid TumorsWho this might be right forSolid Tumor Eli Lilly and Company 9
Testing effectiveness (Phase 2)Looking for participantsNCT07350707What this trial is testingDiagnostic Value of CXCR4-targeted PET/CT in ACTH-dependent and Independent Cushing's SyndromeWho this might be right forCushing s Syndrome Peking Union Medical College Hospital 160
Early research (Phase 1)Study completedNCT04274738What this trial is testingMavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4Who this might be right forWaldenstrom's Macroglobulinemia X4 Pharmaceuticals 16
Not applicableUnknownNCT00174096What this trial is testingThe Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell CarcinomaWho this might be right forLaryngeal CancerHypopharyngeal CancerMetastasis National Taiwan University Hospital 100
Very early researchStudy completedNCT03020524What this trial is testingAutologous CD4 T-Cells in HIV (C34-CXCR4)Who this might be right forHiv University of Pennsylvania 9